For the launch of their first ever Virtual APSCVIR ASM to be held 26-28 February 2021, APSCVIR is offering 20 complimentary registrations to IRSA members. Complimentary registration will be offered to interested members on a first come, first serve basis so we encourage you to please register your interest to avoid missing out.
The Australian recommendations for the management of hepatocellular carcinoma were developed by more than sixty expert clinicians with the principle aim of improving the standard of care provided to patients suffering with this condition in Australia. This online, unabridged version of the recommendations provides detailed background information including technical notes.
Expressions of Interest are NOW OPEN for the position of ‘Member’ of this newly created Sub-Committee.
Through the years, GEST has been notorious for delivering groundbreaking education and innovation in embolization. GEST Meets Virtual 2020 is offering complimentary* access to the live sessions on September 4-6, 2020. There are 21 additional on-demand embolization sessions available at a fee for a chance to earn up to 52.25 CME credits! *Attendees claiming CME credits for the live sessions will be charged a fee.
In 2016, IRSA applied to MSAC to restore public funding for a selected patient group likely to benefit from early vertebroplasty. The application was based on the VAPOUR trial. We are pleased to announce MSAC has supported the application for the patient subgroup in the VAPOUR trial who showed greatest benefit from vertebroplasty. The decision is published on the MSAC website as a Public Summary Document (PSD).